Price Over Earnings Overview: Boston Scientific
Portfolio Pulse from Benzinga Insights
Boston Scientific Inc.'s stock price is currently at $53.24, after a 0.34% decrease. However, the company's stock has increased by 3.47% over the past month, and by 26.17% over the past year. The company's P/E ratio is 89.03, higher than the aggregate P/E ratio of 73.45 of the Health Care Equipment & Supplies industry, indicating that the stock may be overvalued.
September 13, 2023 | 2:45 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Boston Scientific's stock price has decreased by 0.34% to $53.24. However, the stock has increased by 3.47% over the past month and 26.17% over the past year. The company's P/E ratio of 89.03 is higher than the industry average, suggesting that the stock may be overvalued.
Boston Scientific's stock price has decreased slightly in the current market session, but has shown significant growth over the past month and year. The company's P/E ratio is higher than the industry average, which could suggest that the stock is overvalued. However, a high P/E ratio can also indicate that investors expect the company to perform well in the future.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100